Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H17BrF2N4O3S |
| Molecular Weight | 547.372 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](NC(=O)C1=CC=C(Br)C=C1NS(=O)(=O)C2=CC=CC3=C2N=CC=N3)C4=CC=C(F)C=C4F
InChI
InChIKey=TZKCPFFVWLRNRZ-CYBMUJFWSA-N
InChI=1S/C23H17BrF2N4O3S/c1-13(16-8-6-15(25)12-18(16)26)29-23(31)17-7-5-14(24)11-20(17)30-34(32,33)21-4-2-3-19-22(21)28-10-9-27-19/h2-13,30H,1H3,(H,29,31)/t13-/m1/s1
| Molecular Formula | C23H17BrF2N4O3S |
| Molecular Weight | 547.372 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:55:10 GMT 2025
by
admin
on
Wed Apr 02 19:55:10 GMT 2025
|
| Record UNII |
MD7V3X3WJJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
MD7V3X3WJJ
Created by
admin on Wed Apr 02 19:55:10 GMT 2025 , Edited by admin on Wed Apr 02 19:55:10 GMT 2025
|
PRIMARY | |||
|
11307323
Created by
admin on Wed Apr 02 19:55:10 GMT 2025 , Edited by admin on Wed Apr 02 19:55:10 GMT 2025
|
PRIMARY | |||
|
844645-08-5
Created by
admin on Wed Apr 02 19:55:10 GMT 2025 , Edited by admin on Wed Apr 02 19:55:10 GMT 2025
|
PRIMARY | |||
|
300000051553
Created by
admin on Wed Apr 02 19:55:10 GMT 2025 , Edited by admin on Wed Apr 02 19:55:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
OFF TARGET->WEAK INHIBITOR |
BINDING
Ki
|
||
|
TARGET -> INHIBITOR |
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Candidate for clinical investigation for the treatment of GORD.
|
